Home
|
Site Map
|
Contact
| Search
About Eiger
Corporate Overview
Management Team
Board of Directors
Development
Development Pipeline
Inhibitors of NS4B-RNA
NS4B Amphipathic Helix
Science and Medicine
NS4B
Replication Complex
Hepatitis C
Media
Press Releases
Presentations & Publications
Resources
Press Releases
View Archive:
2010
| 2009
August 17, 2009
Industry Veteran with Business Development and Transactional Expertise Joins Eiger Board of Directors
August 10, 2009
Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
August 04, 2009
Eiger BioPharmaceuticals Acquires Exclusive License to Novel Hepatitis C Virus (HCV) Technology From Stanford University
February 25, 2009
Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round
